References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020; 70(1):7–30. doi:https://doi.org/10.3322/caac.21590.
- van der Meer DJ, Kramer I, van Maaren MC, et al. Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989-2017. Int J Cancer. 2020; 30. doi:https://doi.org/10.1002/ijc.33417.
- Soerjomataram I, Louwman MW, Ribot JG, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008; 107(3):309–330. doi:https://doi.org/10.1007/s10549-007-9556-1.
- Cardoso F, Kyriakides S, Ohno S, ESMO Guidelines Committee. Electronic address: [email protected], et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(8):1194–1220. Aug 1. doi:https://doi.org/10.1093/annonc/mdz173.
- Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–933. doi:https://doi.org/10.1016/S1470-2045(10)70207-2.
- Goonawardena J, Yong C, Law M. Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis. Am J Surg. 2020; 220(3):665–676. doi:https://doi.org/10.1016/j.amjsurg.2020.02.001.
- Gennaro M, Listorti C, Mariani L, et al. Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer. Eur J Surg Oncol. 2020; Nov 1:S0748-7983(20)30868-4. doi:https://doi.org/10.1016/j.ejso.2020.10.031.
- Dietz JR, Moran MS, Isakoff SJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487–497. doi:https://doi.org/10.1007/s10549-020-05644-z.
- -Curigliano G, Cardoso MJ, Poortmans P, editorial board of The Breast, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8–16. doi:https://doi.org/10.1016/j.breast.2020.04.006.
- Indini A, Aschele C, Cavanna L, et al. Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. Eur J Cancer. 2020; 132:17–23. doi:https://doi.org/10.1016/j.ejca.2020.03.024.
- Bogani G, Apolone G, Ditto A, et al. Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups. J Gynecol Oncol. 2020; 31(6):e92.doi:https://doi.org/10.3802/jgo.2020.31.e92.
- Cavaliere D, Parini D, Marano L, et al. Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology. Updates Surg. 2020; 12:1–9. doi:https://doi.org/10.1007/s13304-020-00921-4.
- Al‐Shamsi HO, Alhazzani W, Alhuraiji A, et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international collaborative group. Oncologist. 2020;25(6):e936–e945. doi:https://doi.org/10.1634/theoncologist.2020-0213.
- Ahmed M. Optimizing breast cancer surgery during the COVID-19 pandemic. Breast Cancer. 2020; 27(6):1045–1047. doi:https://doi.org/10.1007/s12282-020-01160-6.
- Yüksel C, Çulcu S, Doğan L. The effects of modified lymphoscintigraphy techniques on sentinel lymph node biopsy success during the COVID-19 pandemic period. J Invest Surg. 2020; 15:1–6. doi:https://doi.org/10.1080/08941939.2020.1859022.
- Leysen L, Beckwée D, Nijs J, et al. Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis. Support Care Cancer. 2017; 25(12):3607–3643. doi:https://doi.org/10.1007/s00520-017-3824-3.
- Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014; 15(12):1303–1310. Epub 2014 Oct 15. doi:https://doi.org/10.1016/S1470-2045(14)70460-7.
- Smith TW, Jr, Wang X, Singer MA, et al. Enhanced recovery after surgery: A clinical review of implementation across multiple surgical subspecialties. Am J Surg. 2020; 219(3):530–534. Mar. doi:https://doi.org/10.1016/j.amjsurg.2019.11.009.
- Bogani G, Sarpietro G, Ferrandina G, et al. Enhanced recovery after surgery (ERAS) in gynecology oncology. Eur J Surg Oncol. 2020; 28:S0748-7983(20)30867-2. doi:https://doi.org/10.1016/j.ejso.2020.10.030.